The Aim of This Study is to Compare the Effects of Two Different Topical Agents (KLOROBEN® and KLORHEX PLUS®) Used in the Surgical Extraction of Mandibular Bilateral Mesioangular Impacted Third Molars on Postoperative Pain, Edema, and Trismus.
Investigation of the Effects of Chlorhexidine Gluconate + Benzydamine Hydrochloride and Chlorhexidine Gluconate + Flurbiprofen on Pain, Edema, and Trismus Following Mandibular Impacted Third Molar Extraction
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to compare the effects of two commonly used topical mouth sprays on pain, swelling, and limitation of mouth opening after surgical removal of impacted lower wisdom teeth. A total of 40 adult patients who require the removal of both lower impacted wisdom teeth will participate in this study. Each patient will undergo two separate surgical procedures, with a healing period between them. After each surgery, one of the two topical agents will be applied to the surgical area. The order of the treatments will be randomly assigned. The study is designed so that neither the patients nor the clinician evaluating the outcomes will know which topical agent is used at each session. Pain levels, facial swelling, and mouth opening will be measured at specific time points after surgery. The results will help determine whether one topical treatment is more effective than the other in reducing postoperative discomfort and improving recovery. The information obtained from this study may contribute to improving postoperative care following wisdom tooth surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 19, 2025
CompletedFirst Submitted
Initial submission to the registry
February 8, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedMarch 25, 2026
March 1, 2026
4 months
February 8, 2026
March 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Postoperative pain intensity assessed by Visual Analog Scale (VAS)
Postoperative pain intensity assessed by the Visual Analog Scale (VAS, 0-10 cm), where 0 indicates no pain and 10 indicates worst imaginable pain; higher scores indicate greater pain intensity.
From 30 minutes to 168 hours after surgery
Postoperative facial swelling measurements
Postoperative facial swelling measured by linear facial distances (in centimeters) including tragus to pogonion, tragus to labial commissure, and mandibular angle to lateral canthus; higher values indicate greater swelling.
Preoperatively, postoperative day 2 and postoperative day 7
Maximum mouth opening (trismus assessment)
Trismus will be evaluated by measuring the maximum interincisal distance between the upper and lower central incisors using a ruler.
Preoperatively, postoperative day 2 and postoperative day 7
Secondary Outcomes (1)
Postoperative analgesic consumption
From the day of surgery to postoperative day 7
Study Arms (2)
Kloroben Topical Spray Group
EXPERIMENTALFollowing surgical extraction of the impacted mandibular third molar, Kloroben topical spray containing chlorhexidine gluconate and benzydamine hydrochloride is applied to the surgical site. Patients use the spray postoperatively according to the study protocol, and postoperative pain, swelling, and trismus are evaluated.
Klorhex Plus Topical Spray Group
ACTIVE COMPARATORFollowing surgical extraction of the impacted mandibular third molar, Klorhex Plus topical spray containing chlorhexidine gluconate and flurbiprofen is applied to the surgical site. Patients use the spray postoperatively according to the study protocol, and postoperative pain, swelling, and trismus are evaluated.
Interventions
Kloroben topical spray containing chlorhexidine gluconate and benzydamine hydrochloride is applied to the surgical site immediately after impacted mandibular third molar extraction and used postoperatively according to the study protocol to reduce pain, swelling, and trismus.
Klorhex Plus topical spray containing chlorhexidine gluconate and flurbiprofen is applied to the surgical site immediately after impacted mandibular third molar extraction and used postoperatively according to the study protocol to reduce pain, swelling, and trismus.
Eligibility Criteria
You may qualify if:
- Adults aged between 18 and 50 years
- Indication for bilateral impacted mandibular third molar extraction
- ASA physical status I or II
- No antibiotic use within the previous two weeks
- No analgesic use within the previous 12 hours
- Ability to provide written informed consent
You may not qualify if:
- ASA physical status III to V
- Pregnancy or breastfeeding
- Known allergy to chlorhexidine, benzydamine, or flurbiprofen
- Smoking more than one pack per day
- History of substance abuse
- Presence of systemic diseases that may affect wound healing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara Unıversity Faculty of Dentistry
Istanbul, Maltepe, 34840, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Monitor Clinician
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
February 8, 2026
First Posted
February 17, 2026
Study Start
April 20, 2025
Primary Completion
August 15, 2025
Study Completion
October 19, 2025
Last Updated
March 25, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to patient confidentiality, institutional policies, and local ethical regulations.